Global X Funds Global X HealthTech ETF(HEAL · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $23.00 – $33.59
- YTD
- +0.07%
- IV Rank (30D)
- 18.07
- Straddle Price
- $2.50
- P/C Vol Ratio
- 0.00
Global X Funds Global X HealthTech ETF (HEAL) ETF
- Exchange
- XNAS
- Inception
- 2020-07-29
- Has Options
- Yes
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2025-12-30 | 2026-01-07 | $0.0718 | CD |
| 2025-06-27 | 2025-07-07 | $0.0082 | CD |
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| IQV | IQVIA HOLDINGS INC | 6.36% | Equity (US) | US |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 5.86% | Equity (US) | US |
| TEM | TEMPUS AI INC-CL A | 5.47% | Equity (US) | US |
| OSCR | OSCAR HEALTH INC - CLASS A | 5.36% | Equity (US) | US |
| DXCM | DEXCOM INC | 5.21% | Equity (US) | US |
| — | PRO MEDICUS LTD | 4.27% | Cash/Money Market | AU |
| GEHC | GE HEALTHCARE TECHNOLOGY | 3.97% | Equity (US) | US |
| RMD | RESMED INC | 3.96% | Equity (US) | US |
| HIMS | HIMS & HERS HEALTH INC | 3.91% | Equity (US) | US |
| WAY | WAYSTAR HOLDING CORP | 3.46% | Equity (US) | US |
| — | KONINKLIJKE PHILIPS NV | 3.39% | Equity (Foreign) | NL |
| — | DEMANT A/S | 3.33% | Cash/Money Market | DK |
| ISRG | INTUITIVE SURGICAL INC | 3.19% | Equity (US) | US |
| IRTC | IRHYTHM HOLDINGS INC | 3.05% | Equity (US) | US |
| PODD | INSULET CORP | 2.83% | Equity (US) | US |
| HTFL | HEARTFLOW INC | 2.80% | Equity (US) | US |
| DOCS | DOXIMITY INC-CLASS A | 2.80% | Equity (US) | US |
| TMDX | TRANSMEDICS GROUP INC | 2.73% | Equity (US) | US |
| HNGE | HINGE HEALTH INC-A | 2.60% | Equity (US) | US |
| NRIX | NURIX THERAPEUTICS INC | 1.94% | Equity (US) | US |
| — | ALIBABA HEALTH INFORMATION T | 1.90% | Equity (US) | — |
| PRVA | PRIVIA HEALTH GROUP INC | 1.86% | Equity (US) | US |
| RXRX | RECURSION PHARMACEUTICALS-A | 1.70% | Equity (US) | US |
| LFST | LIFESTANCE HEALTH GROUP INC | 1.69% | Equity (US) | US |
| BFLY | BUTTERFLY NETWORK INC | 1.59% | Equity (US) | US |
| SDGR | SCHRODINGER INC | 1.56% | Equity (US) | US |
| — | 4DMEDICAL LTD | 1.51% | Cash/Money Market | AU |
| INSP | INSPIRE MEDICAL SYSTEMS INC | 1.51% | Equity (US) | US |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 1.41% | Equity (US) | US |
| ALHC | ALIGNMENT HEALTHCARE INC | 1.21% | Equity (US) | US |
| NVCR | NOVOCURE LTD | 1.12% | Equity (US) | — |
| ASTH | ASTRANA HEALTH INC | 1.11% | Equity (US) | US |
| OMCL | OMNICELL INC | 1.06% | Equity (US) | US |
| TNDM | TANDEM DIABETES CARE INC | 0.94% | Equity (US) | US |
| TDOC | TELADOC HEALTH INC | 0.85% | Equity (US) | US |
| PRCT | PROCEPT BIOROBOTICS CORP | 0.83% | Equity (US) | US |
| KMTS | KESTRA MEDICAL TECHNOLOGIES | 0.57% | Equity (US) | — |
| — | XVIVO PERFUSION AB | 0.54% | Cash/Money Market | SE |
| — | SEERS CO LTD | 0.47% | Cash/Money Market | — |
| — | OTHER PAYABLE & RECEIVABLES | 0.03% | Equity (US) | — |
| — | CASH | 0.01% | Cash/Money Market | — |
| — | HONG KONG DOLLAR | 0.00% | Cash/Money Market | HK |
| — | TAIWAN DOLLAR | 0.00% | Cash/Money Market | — |
| Category | Weight | Value | Positions |
|---|---|---|---|
| Short-term investment | 4.01% | $1.4M | 1 |
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -3.02% | 1 |
| Feb | -7.87% | 1 |
| Mar | -8.44% | 1 |
| Apr | +4.12% | 2 |
| May | +6.09% | 2 |
| Jun | +7.52% | 2 |
| Jul | -4.36% | 2 |
| Aug | +4.61% | 2 |
| Sep | +0.50% | 2 |
| Oct | -0.41% | 1 |
| Nov | +3.08% | 1 |
| Dec | -6.60% | 1 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report - HEAL
Executive Summary
BULLISH (Confidence Level: 7/10) Key drivers: Recent positive news headlines, bullish momentum signals, and moderate volatility. Primary risks: Overbought RSI, potential for a pullback if IV premium normalizes.
Investment thesis: HEAL is poised for short-term upside due to the acquisition news and strong momentum indicators. However, caution is advised with the stock trading at overbought levels.
Recent news sentiment impact: The neutral news headline from Benzinga did not significantly impact the stock's price movement.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Uptrend, Medium-term (1-3 months): Bullish, Long-term (3-12 months): Uptrend
Support/Resistance Levels:
- Upper Bollinger Band: $30.68
- Middle Band: $28.40
- Lower Band: $26.12
- SMA 20: $28.40
- SMA 50: $27.78
- SMA 200: $27.45
Momentum Signals:
- RSI interpretation: Overbought (72.84), potential sell signal.
- MACD signal: Bullish, indicating continued momentum.
- Bollinger Bands position: Neutral, with the price touching the upper band.
Volume Analysis: Volume SMA 20: 12140.65, On-Balance Volume (OBV): -222614.86, and Volume Rate of Change: -41.76%. These signals suggest moderate institutional interest and a potential pullback.
News & Sentiment Analysis
Recent Headlines Summary: Neutral news headline from Benzinga, no significant impact on the stock's price movement.
Sentiment Assessment: Neutral sentiment due to the lack of market-moving news headlines.
Catalyst Identification: No immediate catalysts identified, but the acquisition news could provide a medium-term boost.
Market Narrative: The technical signals and moderate volatility align with the bullish momentum indicators, supporting the short-term uptrend.
Risk & Volatility Assessment
Beta Interpretation: 0.99 (Moderate volatility), indicating the stock generally follows market movements.
Volatility Regime: Current vs historical volatility levels: Moderate (23.8% HV20).
Options Market Signals: IV Rank: 44.8% (Medium), Current IV: 89.3%, Expected Move: $2.83, Volume Flow: 2 calls vs 2 puts, Open Interest: 2 calls vs 0 puts.
Downside Protection: Support levels at the Lower Bollinger Band ($26.12) and SMA 200 ($27.45).
Market Context & Positioning
Sector Performance: Relative strength within the Healthcare sector.
Institutional Activity: Moderate volume flow, indicating some institutional interest.
Correlation Analysis: R-squared interpretation: Strong correlation with the broader market (0.55).
Relative Valuation: HEAL is trading near its upper Bollinger Band and above its SMA 50, suggesting a relatively strong position within its trading range.
Key Levels & Action Items
Critical Price Levels: Lower Bollinger Band ($26.12), SMA 200 ($27.45), Upper Bollinger Band ($30.68).
Breakout/Breakdown Levels: Break above the upper Bollinger Band ($30.68) or below the lower Bollinger Band ($26.12).
Time-Sensitive Catalysts: None identified.
Risk Management: Consider setting a stop-loss level at the Lower Bollinger Band ($26.12) and position sizing based on risk tolerance.
- IV Rank (30D)
- 18.07
- IV Rank (7D)
- 18.07
- Avg IV
- 48.8%
- Straddle (30D)
- $2.50
- Straddle (7D)
- $2.50
- P/C Volume
- 0.00
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
- Beta (1Y vs SPY)
- 0.97
- Correlation (SPY)
- 54.4%
- R²
- 0.30
- Ann. Volatility
- 23.2%
- SPY Volatility
- 13.0%
Moderate volatility - stock generally follows market
Click any bar to view the full quote for that stock.
| Symbol | Name | Weight % | Price | 1 Day | 1 Week | 1 Month |
|---|